...
首页> 外文期刊>Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics >Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues.
【24h】

Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues.

机译:猪眼组织中血管紧张素转换酶ACE1和ACE2的活性以及生物活性肽的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: An active local renin-angiotensin system (RAS) has recently been found in the human eye. The aim of the present study was to compare the activities of central RAS enzymes (ACE1 and 2) in porcine ocular tissues, morphologically and physiologically close to the human eye. In addition, the effects of three ACE-inhibitory tripeptides on these enzymes were evaluated. METHODS: Enucleated fresh porcine eyes were used. Activities of ACE1 and ACE2 and their inhibition by bioactive tripeptides (Ile-Pro-Pro, Val-Pro-Pro, Leu-Pro-Pro) as well as by a standard ACE-inhibitor captopril were assayed in the vitreous body, the retina and the ciliary body using fluorometric detection methods. RESULTS: Activity of ACE1 as well as ACE2 was found in all tissues evaluated. ACE1 activity was markedly higher in the ciliary body (3.7 +/- 0.7 mU/mg protein) than in retina (0.2 +/- 0.02 mU/mg), whereas ACE2 activities in the ciliary body (0.2 +/- 0.02 mU/mg) and retina (0.2 +/- 0.01 mU/mg) were at the same level. In the vitreous body ACE1 activity (8.2 +/- 0.31 nmol/min/mL) was manifold compared to that of ACE2 (0.1 +/- 0.02 nmol/min/mL). The tripeptides inhibited ACE1 at one-thousandth of the concentration needed to inhibit ACE2. All peptides studied evinced about equal inhibitory activities. CONCLUSION: To our knowledge the present findings constitute the first evidence of ACE2 activity in the ciliary and vitreous bodies, in addition to previously described activity in the retina. The known favorable effects of ACE2 products vs. those of ACE1 suggest a counterbalancing interaction of these two enzyme homologues in physiological regulation of ocular circulation and pressure and possible protective role in certain ophthalmic disorders such as glaucoma and diabetic retinopathy.
机译:目的:最近在人眼中发现了活跃的局部肾素-血管紧张素系统(RAS)。本研究的目的是比较形态和生理上接近人眼的猪眼组织中的中央RAS酶(ACE1和2)的活性。此外,评估了三种ACE抑制性三肽对这些酶的作用。方法:使用去核新鲜的猪眼。在玻璃体,视网膜和视网膜中检测了ACE1和ACE2的活性及其对生物活性三肽(Ile-Pro-Pro,Val-Pro-Pro,Leu-Pro-Pro)以及标准ACE抑制剂卡托普利的抑制作用。睫状体采用荧光检测法。结果:在所有评估的组织中均发现了ACE1和ACE2的活性。睫状体内的ACE1活性(3.7 +/- 0.7 mU / mg蛋白)明显高于视网膜中的(0.2 +/- 0.02 mU / mg),而睫状体中的ACE2活性(0.2 +/- 0.02 mU / mg) )和视网膜(0.2 +/- 0.01 mU / mg)处于同一水平。在玻璃体中,ACE1的活性(8.2 +/- 0.31 nmol / min / mL)比ACE2的活性(0.1 +/- 0.02 nmol / min / mL)多。三肽以抑制ACE2所需浓度的千分之一抑制ACE1。所有研究的肽均表现出相同的抑制活性。结论:据我们所知,本研究结果构成了ACE2在睫状体和玻璃体中活动的第一个证据,除了先前描述的视网膜活动。 ACE2产品相对于ACE1的已知有利作用表明,这两种酶同系物在眼循环和压力的生理调节中具有抵消作用,并且在某些眼科疾病如青光眼和糖尿病性视网膜病中可能具有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号